• Site Search
  • Lawyer Search

Venture Intellectual Property

  • Print PDF
  • Subscribe to RSS
  • MoFolder

Intellectual property (IP) strategy – like all business strategy – requires looking around the bend.   A strategic approach requires understanding every aspect of IP law so that the property can be protected in every stage of that lifespan.  Our experienced patent attorneys help companies, investment banks and venture capitalists achieve their business goals and protect their IP through such services as freedom to operate assessments, landscaping analyses, as well as patent portfolio audits.  These activities help reduce intellectual property risks, value the IP, and identify opportunities to strengthen the patent portfolio. 

 

As a firm with deep roots in the technology industry, we regularly assist high tech and life sciences clients.  We were the first to institutionalize a specialized group, our Venture Intellectual Property Group (VIP), to focus on investor-side due diligence.  Our VIP group has performed hundreds of investor-side due diligence matters for some of the most respected venture firms, including Kliener Perkins Kaufield & Byers, InterWest, Polaris Venture Partners, and Sanderling Ventures.  Our team members represent the full spectrum of the life sciences community, having specialties in medical devices, pharmaceuticals, biotechnology, and chemistry.  We also work with large diversified pharmaceutical companies and healthcare service companies.

 

With the largest patent group of any general practice firm, Morrison & Foerster is uniquely positioned to assist clients with their patent needs.  The firm’s attorneys have played a significant role in the creation and protection of many of the landmark patent portfolios in the information technology and life science industries.

 

In addition, the firm’s Venture Intellectual Property group is one of the few specializing in investor-side intellectual property due diligence.  The group is uniquely positioned to identify the legal issues surrounding life sciences and academia-originated technology.
Loading...
Loading...